HP, mPedigree launch anti-counterfeiting trial

Africa's abundant API-absent malaria drug fakes may be getting easier to identify, thanks to Hewlett-Packard and Ghana-based nonprofit mPedigree Network.

The pair expects to launch a six-month trial of an authentication system in Ghana and Nigeria. Some 125,000 malaria pill packets will come with a 10-digit code concealed by a scratch panel. After users reveal the code, they send it via cell phone text message to an advertised number. The message is forwarded to an HP data center for verification. If it checks out, the user receives an "OK" reply. A "No" reply indicates a fake.

HP and mPedigree, Bloomberg reports, are seeking the involvement of other drugmakers.

Nigeria is also testing another authentication service using a Merck diabetes drug. It incorporates a system developed by Boston-based Sproxil; Nigeria has also worked with Sproxil and Biofem Pharmaceuticals, as reported. And a third company using cell phones for drug authentication is PharmaSecure; its system is being trialed in India.

- see the Bloomberg report


Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.